TuHURA Biosciences received FDA clearance to start a Phase 1b trial for TBS-2025, a VISTA-inhibiting antibody targeting relapsed/refractory mutNPM1 Acute Myeloid Leukemia (AML) patients who failed menin inhibitor therapy. This trial will assess safety and efficacy at different doses, addressing a critical unmet need as these patients currently have no approved treatments. Positive results could lead to trial expansion and accelerated approval discussions with the FDA. TuHURA aims to develop novel immunotherapies to overcome resistance in cancer treatment, with TBS-2025 showing promising preclinical survival benefits.
TuHURA Biosciences' recent FDA clearance to begin a Phase 1b trial for its TBS-2025 antibody comes amid a mixed health sector market. For readers following health stocks, here is Pluang's market snapshot as of Sep 14, 2026 18:52 WIB: out of 91 priced US health-sector stocks tradable on Pluang, 50 rose and 28 fell. Notable movers include Smith & Nephew plc (SNN) up 2.76% at USD 28.26, Medtronic PLC (MDT) up 2.55% at USD 93.28, and AbCellera Biologics Inc (ABCL) down 2.30% at USD 10.64.
Sika AG posted a 4.8% sales increase in local currencies for the first nine months of 2026, reaching CHF 8.71 billion despite currency headwinds. The company saw organic growth of 3.5% and improved material margins to 55.4%, with EBITDA rising 1.9% t...
Sika reported a 4.8% sales increase in local currencies for the first nine months of 2026, reaching CHF 8.71 billion despite a negative currency effect. The company improved its material margin to 55.4% and maintained an EBITDA margin of 19.2%, with ...
Aduro Clean Technologies announced its participation in five major industry and investor conferences from October to December 2026. The company will showcase progress in its Hydrochemolytic™ technology for recycling plastics and upgrading crude oils,...
Aduro Clean Technologies announced it will participate in five conferences between October and December 2026, engaging with industry professionals and institutional investors. Key topics include updates on their Hydrochemolytic™ technology for recycl...
On October 22, US spot Bitcoin ETFs experienced a significant outflow of $635 million, with BlackRock's iShares Bitcoin Trust (IBIT) accounting for $254 million of the withdrawals. This reversed a strong inflow trend from the previous three days, whe...
